- Report
- November 2024
- 338 Pages
Global
From €3323EUR$3,500USD£2,803GBP
€4747EUR$5,000USD£4,004GBP
- Report
- August 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- June 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- January 2025
- 185 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- July 2024
- 182 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- May 2024
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- April 2024
- 185 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- January 2025
- 185 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- June 2024
- 183 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- May 2024
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- May 2024
- 182 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- May 2024
- 185 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- April 2024
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- October 2024
- 200 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- August 2024
- 200 Pages
Global
From €4698EUR$4,949USD£3,963GBP
- Report
- June 2024
- 250 Pages
Global
From €4742EUR$4,995USD£4,000GBP
- Report
- September 2024
- 58 Pages
Asia Pacific
From €2777EUR$2,925USD£2,342GBP
€3085EUR$3,250USD£2,603GBP

Epigenetics is a field of genomics that studies the regulation of gene expression without altering the underlying DNA sequence. It is a rapidly growing field of research that has the potential to revolutionize the understanding of gene regulation and its role in disease. Epigenetics is the study of how environmental factors, such as diet, lifestyle, and exposure to toxins, can affect gene expression. It is also used to study the effects of aging and the development of cancer.
Epigenetics has become an important tool in the diagnosis and treatment of many diseases, including cancer, diabetes, and neurological disorders. It is also being used to develop new therapies and treatments for a variety of diseases.
The epigenetics market is expected to grow significantly in the coming years, driven by the increasing demand for personalized medicine and the development of new technologies. Companies in the epigenetics market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Merck KGaA, and PerkinElmer. Show Less Read more